The UK takes the lead position when it comes to patent filings for point-of-care diagnostics in Europe, according to new research from Landon IP, the patent analytics and consulting arm of intellectual property management specialist CPA Global, and intellectual property firm Marks & Clerk.
The research, a comprehensive patent landscape study undertaken for the Longitude Prize, shows that the UK is second only to the US in the number of first fillings for patent applications directed to point-of-care diagnostics tests since 2009.
After the US (where 258 out of 332 patent families were first filed) and the UK (26 out of 332), Germany, Australia, Singapore and South Korea are the next most common jurisdictions for patent first filings (six each).
The Longitude Prize is a £10 million prize fund aiming to revolutionise global healthcare and conserve antibiotics for future generations. It is run by innovation charity Nesta with the UK's innovation agency, Innovate UK as funding partner.
